You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
豐原藥業(000153.SZ):擬收購泰格科技100%股權、其主營為維生素及相關精細化工產品的研產銷
格隆匯 01-03 17:47

格隆匯1月3日丨豐原藥業(000153.SZ)公佈,公司擬以發行股份方式購買泰格生物持有的泰格科技100%股權,並向不超過35名特定投資者發行股份募集配套資金。此次交易完成後,泰格科技將成為公司全資子公司。

截至預案簽署日,此次交易標的資產的審計、評估工作尚未完成,此次交易標的資產的預估值及交易價格尚未確定。此次交易標的資產的最終交易價格將以具有證券、期貨相關業務資格的評估機構對標的資產截至評估基準日的價值進行評估而出具的評估報吿的評估結果為基礎,由交易各方協商確定。此次交易標的資產的評估結果和交易價格將在重組報吿書中予以披露。

此次交易前,公司主營業務包括醫藥製造和商業流通。其中醫藥製造涉及生物藥、化學藥及中藥的研發、生產和銷售,主要產品涵蓋解熱鎮痛、婦兒、神經系統、心血管、泌尿系統、營養類、抗生素、原料藥等系列產品;商業流通涉及醫藥配送和藥房零售,現已形成高效、全優、多品種的醫藥供應服務體系。標的資產主營業務為維生素及相關精細化工產品的研發、生產和銷售,目前主要產品包括D-泛酸鈣、D-泛醇、肌酸、肌氨酸等。

通過此次交易,公司將進一步豐富業務範圍,有利於增強公司盈利能力,提高公司資產質量,為公司持續經營提供堅實保障。

根據相關規定,經向深圳證券交易所申請,公司股票將於2023年1月4日開市起復牌。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account